It remains unclear whether HIV-associated immune dysfunction and inflammation are linked to severe COVID-19 disease outcomes [163, 164] or whether paradoxically a low CD4+ T cell count ameliorate disease severity [134]. This evidence concerns the gene CD4 and immune system disorder.